Back to Search
Start Over
The GPR84 Antagonist GLPG1205 Reduces Features of Disease in Experimental Severe Asthma.
- Source :
- American Journal of Respiratory Cell & Molecular Biology; May2024, Vol. 70 Issue 5, p424-427, 4p
- Publication Year :
- 2024
-
Abstract
- The article discusses the potential therapeutic impact of the GPR84 antagonist GLPG1205 in experimental severe asthma. It emphasizes GPR84's role in lung inflammation and metabolism, as well as the compound's effect on reducing airway inflammation and hyperresponsiveness, particularly in neutrophilic inflammation and steroid-insensitive features.
Details
- Language :
- English
- ISSN :
- 10441549
- Volume :
- 70
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- American Journal of Respiratory Cell & Molecular Biology
- Publication Type :
- Academic Journal
- Accession number :
- 176929009
- Full Text :
- https://doi.org/10.1165/rcmb.2023-0221LE